MicroSpray Technologies’ mission is to revolutionise ultra-fine particle manufacturing for pharmaceutical and research industries using an innovative, simple and cost-effective spray technology.
Currently, biopharmaceutical industries use costly chemical methods to manufacture microspheres, which rely on batch-type processes, have a low throughput and require a lot of bench space. This is costly, having poor processing efficiency (i.e. polymer-to-particle conversion) and the consumption of chemical precursors is very high. MicroSpray Technologies will to bring to market a novel spray-manufacturing system that increases particle production rates by up to 1600% in comparison to current conventional methods. This process is safer, sustainable and economical, with dramatically reduced size complexity. Our device enables reproducible control over particle size and therefore allows clinicians to administer control over the rate at which drugs are delivered to patients, cutting down on repeated administrations currently costing the NHS £900M/year. Through our platform process, we can find innovative ways of creating drug delivery carriers and subsequently open up new applications previously unexplored.
This platform technology (known as the electrospray) is considered the “holy grail” of particle manufacture in aerosol generation methods and can now provide the controlled production of polymeric particles for high-value added applications, such as pharmaceutical drug delivery.
YOU MIGHT ALSO BE INTERESTED IN